Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Vopr Onkol ; 59(5): 585-90, 2013.
Article in Russian | MEDLINE | ID: mdl-24260885

ABSTRACT

The aim of this study was to identify variants of retroperitoneal vascular structure during systematic paraaortic lymphadenectomy in patients with early-stage cervical cancer and to investigate the effects of these anomalies in surgical procedures. 79 patients who had undergone systematic paraaortic and bilateral pelvic lymph node dissection between 2006 and 2013 were included. Normal architecture and structural anomalies of inferior vena cava, renal arteries and veins, common iliac vein and ovarian vessels were studied. Variants of major retroperitoneal vascular structure were present in 10 patients (12.7%). Variants of renal vessels were identified in 8 patients (10.1%): supernumerary renal arteries and veins observed in 5 patients (6.3%); retroaortic left renal vein type I and II - in 3 patients (3.8%). A rare variant as double vena cava inferior was detected in 1 patient (1.3%). Vessel injury was present no one case in patients with variants of vascular structures and in 1 of 69 (1.4%) patients without variants of retroperitoneal vascular structure. There was no difference in intraoperative hemorrhage, transfusion red blood cell and rate of intraoperative hemoglobin between the groups. Thus the acquisition of knowledge and visualization of vascular variations decrease complications during systematic paraaortic and bilateral pelvic lymphadenectomy.


Subject(s)
Lymph Node Excision , Retroperitoneal Space/blood supply , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/surgery , Adult , Aorta , Female , Humans , Iliac Vein/abnormalities , Lymph Nodes/pathology , Lymph Nodes/surgery , Middle Aged , Neoplasm Staging , Ovary/blood supply , Pelvis , Renal Artery/abnormalities , Renal Veins/abnormalities , Vena Cava, Inferior/abnormalities
2.
Voen Med Zh ; 326(11): 15-22, 111, 2005 Nov.
Article in Russian | MEDLINE | ID: mdl-16404901

ABSTRACT

Radiotherapy is one of the main methods of malignant tumor treatment. The radiotherapy department in Burdenko Main Military-and-clinical Hospital as a part of a radiological center has been working for 40 years. During vhis period it has constantly been developing its technical base, quality of irradiation and professionalism of its staff. And nowadays at the modern stage there exists a real perspective of future development of radiological treatment for servicemen and their families' members basing on the radiotherapy department in Burdenko MMCH.


Subject(s)
Hospitals, Military/organization & administration , Radiology Department, Hospital/organization & administration , History, 20th Century , History, 21st Century , Hospitals, Military/history , Quality of Health Care , Radiation Oncology/history , Radiation Oncology/standards , Radiology Department, Hospital/history , Radiotherapy, High-Energy/history , Radiotherapy, High-Energy/instrumentation , Radiotherapy, High-Energy/standards , Russia , Workforce
5.
Voen Med Zh ; 324(10): 34-41, 96, 2003 Oct.
Article in Russian | MEDLINE | ID: mdl-14671893

ABSTRACT

Non-Hodgkin's lymphomas (NHL) are the heterogeneous group of lymphoproliferative malignancies with distinct morphological, immuno-histochemical and genetic criteria of diagnosis, different character of clinical course, sensitivity to different treatment methods and disease prognosis. The WHO classification (1997) encompasses all the lymphoproliferative neoplasms. The NHL can be divided into 2 prognostic groups: the indolent lymphomas and the aggressive non-Hodgkin's lymphomas. The indolent NHL types have a relatively favorable clinical prognosis, with median survival as long as 10 years, but they usually are not curable in advanced clinical stages. Early-stage (I and II) indolent NHL can be effectively treated with radiation therapy alone. In advanced stages of indolent NHL the chemotherapy is conducted.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cyclophosphamide/therapeutic use , Disability Evaluation , Doxorubicin/therapeutic use , Hydrocortisone/therapeutic use , Lymphoma, Non-Hodgkin/drug therapy , Methotrexate/therapeutic use , Methylprednisolone/therapeutic use , Military Personnel , Prednisone/therapeutic use , Vincristine/therapeutic use , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Chlorambucil/administration & dosage , Chlorambucil/therapeutic use , Cohort Studies , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Humans , Hydrocortisone/administration & dosage , Lymphoma, Non-Hodgkin/pathology , Methotrexate/administration & dosage , Methylprednisolone/administration & dosage , Middle Aged , Neoplasm Staging , Prednisone/administration & dosage , Russia , Vincristine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...